Le dividende de la longévité : Une révolution de la santé personnalisée

Within the next 15 years, personalized medicine driven by AI will significantly extend healthy lifespans, not merely lifespans, by proactively identifying and mitigating age-related diseases at their earliest stages. This will manifest in widespread adoption of preventative genomic therapies and AI-powered diagnostic tools, resulting in a substantial reduction in age-related morbidity and a dramatic shift towards a healthier, more extended aging experience.